ENFN Enfusion
Enfusion price
-1.20% Past Week
Market Cap
766.19M
Day’s Range
52W Range
Volume (3M)
378.55K
Price-Earnings Ratio
278.64
Revenue
188.35M
About Enfusion
Enfusion provides cloud-based investment management software. These services include the management of risks, portfolios, accounts, and orders to unify front, middle, and back-office functions. Headquartered in Chicago, Illinois, the company was founded in 1998 and operates internationally. As of October 2021, Enfusion has eight offices in seven countries.
The company went public in October 2021. Enfusion sold 15.32 million shares between $15 and $17 apiece and raised approximately $260m with its IPO. This offering gave the company an approximate market value of $1.92bn. Enfusion trades on the NYSE under the ENFN stock ticker.
Track this instrument on eToro for updates and news on the ENFN share price.
Show MoreOleg Movchan, MBA
CEO
1.1K
Employees
2006
Founded
Chicago, Illinois, US
HQ
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
42
Very Low
Industry
Avg. 48
32
Environment
44
Social
52
Governance
Consensus
Moderate Sell
Price Target
8.00
People Also Bought
- TIGR UP Fintech Holding Limited 6.10%
- CBUS Cibus Inc 2.24%
- EGRX Eagle Pharmaceuticals Inc -8.23%
- TELA TELA Bio Inc -0.36%
- DTC Solo Brands Inc -2.13%